Pharmaceutical company Bionorica from Germany will not leave the Russian market despite the European Union’s sanctions against the Russian Federation. This was reported in the press service of the company. TASS.
According to Bionorica representatives, due to EU sanctions, the company is no longer able to equip and operate a pharmaceutical manufacturing plant in Voronezh. For this reason, a “suitable partner” is sought to ensure the commissioning of the plant. The company emphasized that Bionorica does not intend to leave Russia. It will continue to provide high quality herbal products to the Russian people.
It was previously reported that Switzerland. joined To the 11th package of sanctions of the European Union against the Russian Federation.
Prior to that, the Permanent Representatives of the European Union held a meeting in Brussels. acceptance Expansion of personal sanctions against the Russian Federation against the backdrop of the situation in Ukraine. Personal sanctions against Russia against Ukraine are usually extended every six months.
Former US Treasury extended sanctions against Russia.